Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy

INTRODUCTION: Clozapine is an atypical antipsychotic medication approved for treatment-resistant schizophrenia and suicidal behavior in schizophrenia or schizoaffective disorders. Despite its therapeutic efficacy, clozapine is associated with several adverse effects, including agranulocytosis. In la...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ment Health Clin
Autors principals: Curry, Brent, Palmer, Emma, Mounce, Crystal, Smith, Gilbert, Shah, Vital
Format: Artigo
Idioma:Inglês
Publicat: College of Psychiatric & Neurologic Pharmacists 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007735/
https://ncbi.nlm.nih.gov/pubmed/29955547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2018.03.063
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars